Arbor Biotechnologies, Inc.

Description: Class 5: Engineered nucleic acid sequences for medical purposes; nucleases, fusion proteins, RNAs and biomolecular complexes for modification of cellular genome; gene editing agents for modifying RNA sequences; gene editing agents for modifying DNA sequences at genomic target sites; engineered biomolecular complexes comprised of fusion proteins and RNAs used for modifying nucleic acid sequences in human genomes; engineered biomolecular compound for enhanced regulation and correction of gene expression and mutations, excision and insertion of DNA sequences, and delivery of whole genes and nucleic acid sequences to target sites; gene therapy and cell therapy products in the nature of DNA editing complexes targeting genomic sites
Class 40: Custom biomanufacturing of gene editing complexes; custom biomanufacturing of engineered fusion proteins and nucleic acids for use in Cell and Gene Therapy (CGT)
Class 42: Bioengineering of proteins, nucleic acids, RNAs, and gene editing complexes used in genomic engineering; providing medical scientific research information in the fields of gene editing technologies and genomic engineering

Description: Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use; Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy

Description: Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use; "BIOTECH"; Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy

Description: Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others; Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use; Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy

Description: Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others; Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use; "BIOTECHNOLOGIES"; Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy

Description: Protein and enzyme discovery research for non-medical industrial applications; non-medical industrial application research and development of technologies and computational strategies for high throughput protein and enzyme functional prediction, screening, and characterization; none of the foregoing relating to clinical laboratory testing, pharmaceuticals, or human genetics-related diagnostics

Description: Protein and enzyme discovery research for therapeutic, diagnostic, and industrial applications; research and development of technologies and computational strategies for high throughput protein and enzyme functional prediction, screening, and characterization; research and development of technology in the field of biotechnology; all of the foregoing excluding clinical laboratory testing services